Uromodulin was found to be decreased in patients with hypertension compared to patients without hypertension which is a similar finding to a study done in 2020 demonstrating an inverse relationship with serum uromodulin and arterial hypertension [6]. This evidence concerns the gene UMOD and hypertensive disorder.